TIMP1 and hepatocellular carcinoma: Currently, several studies have proved that ITCs downregulate the expression of MMP-2/-9 and upregulate the expression of TIMP1/2 in HCC in vitro, finally resulting in the inhibition of HCC progression [140,152,153,196].